Cargando…
Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis
Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients. However, there have been no data showing actions on Japanese bone architecture. Here we show that denosumab continuously improves several geometrical parameter...
Autores principales: | Sone, Teruki, Kon, Naohiro, Gaither, Kenneth W., Okubo, Naoki, Osakabe, Taisuke, Nakayama, Yutaka, Fukunaga, Masao, Ito, Masako, Nakamura, Toshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701790/ https://www.ncbi.nlm.nih.gov/pubmed/29188222 http://dx.doi.org/10.1016/j.bonr.2017.11.002 |
Ejemplares similares
-
Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
por: Nakamura, Toshitaka, et al.
Publicado: (2014) -
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017) -
Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women
por: Ohnaru, Kazuhiro, et al.
Publicado: (2013) -
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Geusens, Piet
Publicado: (2009) -
Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)